GenedriveLSE:GDR FCF Yield % is -18.70 as of Jun. 29, 2026. The stock has 4 warning signs investors should review. Among 214 Medical Diagnostics & Research companies, Genedrive ranks worse than 79.91% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Genedrive's FCF Yield % or its related term are showing as below:
LSE:GDR'
s FCF Yield % Range Over the Past 10 Years
Min: -477.7 Med: -57.8 Max: -7.14
Current: -18.7
During the past 13 years, the highest FCF Yield % of Genedrive was -7.14%. The lowest was -477.70%. And the median was -57.80%.
LSE:GDR's FCF Yield % is ranked worse than 79.91% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.455
vs LSE:GDR: -18.70
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Genedrive FCF Yield % Related Terms
Genedrive FCF Yield % Historical Data
* Premium members only.
The historical data trend for Genedrive's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Genedrive's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genedrive FCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Genedrive's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Genedrive's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genedrive (LSE:GDR) has a FCF Yield % of -18.70 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Genedrive and its competitors. According to the industry distribution chart, Genedrive ranks #171 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 79.9%.
Is Genedrive's FCF Yield % too high?
Genedrive's current FCF Yield % is -18.70. Based on the distribution chart, Genedrive ranks #171 out of 214 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Genedrive's FCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Genedrive ranks #171 out of 214 companies for FCF Yield %. This places Genedrive in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Diagnostics & Research company?
A good FCF Yield % depends on the Medical Diagnostics & Research industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Genedrive and its competitors. Genedrive's current FCF Yield % is -18.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genedrive stock overvalued right now?
Genedrive (LSE:GDR) has a current FCF Yield % of -18.70. The current FCF Yield % is -18.70. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Genedrive (LSE:GDR), the current FCF Yield % is -18.70 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Genedrive PLC is a holding company engaged in the molecular diagnostics business. It operates in one operating segment named Diagnostics which is engaged in the Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and use in patient stratification (genotyping), pathogen detection, and other indications. Geographically the majority of the revenue is derived from the United Kingdom and also has its presence in Europe, United States of America and Rest of the World.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:GDR has been successfully added to your 